Twitter Beğeni Hilesi

Great meeting - lot of scientific impact - hopefully leading to some changes and new research in this area of aging and MS.

Thank you to the inspiring people who came together to outline knowledge gaps and develop an action plan to improve #clinicaltrials and safer care for older people living with #MS. Almost 50% of pwMS are now >50yo….National MS Society Frederik Barkhof Xavier Montalban Peter Calabresi Tim Coetzee

Bravo👏! Important research.

Meden meeting in Berlin- excellently organized ☀️by colleagues of @charite- with very productive workshops - 🤰WS details were finalized on a 🚤 trip with great cochairs Georgina Arrambide Sandra Vukusic- with an excellent minimal and extended dataset. Can’t wait for Lyon 2025.

Kerstin Hellwig Charite Georgina Arrambide Very successful MEDEN meeting in Berlin, great progress for rare inflammatory diseases of the central nervous system ! Thank you Kerstin Hellwig and Georgina Arrambide for wonderful moments and productive pregnancy WG 🥰

🍾👏💕

Introducing Lead Guest Editor, Professor Kerstin Hellwig from Ruhr-Universität Bochum, leading our special collection on Women’s Research in Neurological Disorders. Join us in celebrating and advancing women's contributions in neurology. #WomenInScience #NeurologyResearch

All your excellent female colleagues 💃👯‍♀️🙋‍♀️🤰🤱 -please submit great papers.

Prognose: CDU/CSU stärkste Kraft bei #Europawahl – AfD auf Platz 2. www1.wdr.de/nachrichten/eu…

So important - walking - exercising - still totally underestimated in many health conditions- great journal to publish these results in - although it can be hard - especially in disease like MS to overcome fatigue -

Exposure to anti-cd 20 mabs shortly before or early during pregnancy or lactation does not alter B cell counts in newborns.Are we ready for a label change? 🤱🤰thank you- coauthors and of course a special thanks to all women and their babies. ncbi.nlm.nih.gov/pmc/articles/P…

For all those with MS... ECTRIMS Patient Community Day -👉 bit.ly/3yWAy8S Friday, 20 September 2024 15:00 – 18:00 CEST ONLINE, ONSITE & FREE Expert panel talk on remyelination, emerging therapies, lifestyle modifications & symptom management & MS nursing.

How about fertility? Older mitox data show that women > 35 are especially threatened by permanent amenorrhea.

And more and more sience supports us to combine BF with 💊- if needed in many cornic diseases - in mild to moderate MS we do not need 💊 - but active MS or #NMOSD we might. More convincing data will be shaken ECTRIMS 2024.🤱🤱🤱

I do not think it should it be a major problem- it is timely and modern medicine to combine modern treatment in chronic disease also with 🤰 and 🤱.

🥂thank you- it is a great honor for me and thank you and your family to make this possible- I look forward receiving it ECTRIMS

Thank you ECTRIMS and all colleagues- some became friends for your congrats but also your company on this long journey- by the way I only missed 2 ectrims since my first in Stockholm 98- 2004 Vienna (birth of my daughter ) and miserably Lyon- postdoc in the US no entry visa…

Yes- please submit great papers!

Also true for any rare disease #NMOSD- MOGAD- or rare conditions as pregnancy 🤰 even in more common diseases as MS.

💉protects- still such an important finding! And we need treatments! Also for adults. And the risk for autoimmune diseases is increased- what is 🐓 and 🥚🤷‍♀️